Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lithium citrate tetrahydrate (in reverse-micelle formulation)

EU orphan designation number: EU/3/09/706   
Active ingredient: Lithium citrate tetrahydrate (in reverse-micelle formulation)
Indication: Treatment of Huntington's disease
Sponsor: Medesis Pharma
L’Orée des Mas, avenue du Golf, 34670 Baillargues, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/02/2010 Orphan designation EMEA/OD/095/09 (2010)654 of 28/01/2010